Fig. 1 · Structure

Documents & Downloads

Arbidol HCl

Cat. No. A11663 CAS 131707-23-8
Arbidol is an antiviral treatment for influenza infection used in Russia and China. Arbidol inhibits membrane fusion. Arbidol prevents contact between the virus and target host cells. Fusion between the viral capsid and the cell membrane of the target cell is inhibited. This prevents viral entry to the target cell, and therefore protects it from infection.

In Stock

Publications for Arbidol HCl

2 publications citing this product

  1. Durbadal Ojha, .et al. , Antiviral Res, 2023, Jan; 209 PMID: 36396026
  2. Feng, Yi, .et al. , Current Pharmaceutical Analysis, 2020, 16(3). 231-237(7)

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Cellular Effect

Cell Line Activity Value Description Reference
MDCK CC50 32.92 μM Cytotoxicity against MDCK cells incubated for 1 hr by MTT assay [PMID: 35085860]

Specifications

Manufacturer Adooq Bioscience
CAS Number 131707-23-8
Formula C22H25BrN2O3S.HCl
Molecular Weight 513.88
SMILES
CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3.Cl

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 97 mg/mL (188.75 mM)
Water Insoluble
Ethanol 21 mg/mL (40.86 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Publications

2 publications citing this product

  1. Durbadal Ojha, .et al. , Antiviral Res, 2023, Jan; 209 PMID: 36396026
  2. Feng, Yi, .et al. , Current Pharmaceutical Analysis, 2020, 16(3). 231-237(7)

Added to your cart

View Cart Checkout
Loading...